Previous 10 | Next 10 |
TransMedics Group, Inc. Announces Proposed Offering of $300 Million of Convertible Senior Notes Due 2028 PR Newswire ANDOVER, Mass. , May 8, 2023 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transfor...
2023-05-02 01:05:05 ET Transmedics Group, Inc. (TMDX) Q1 2023 Earnings Conference Call May 01, 2023, 16:30 ET Company Participants Brian Johnston - Gilmartin Group Waleed Hassanein - Founder, President, CEO & Director Stephen Gordon - CFO, Treasurer & Sec...
2023-05-01 16:14:24 ET TransMedics Group press release ( NASDAQ: TMDX ): Q1 GAAP EPS of -$0.08 beats by $0.19 . Revenue of $41.6M (+161.6% Y/Y). Sees FY 2023 revenue of $160 million to $170 million. TMDX had guided FY 2023 revenue of $138 million to $145 milli...
TransMedics Reports First Quarter 2023 Financial Results PR Newswire ANDOVER, Mass. , May 1, 2023 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with ...
TransMedics Releases Inaugural Environmental, Social & Governance (ESG) Report TransMedics Releases Inaugural Environmental, Social & Governance (ESG) Report PR Newswire ANDOVER, Mass. , May 1, 2023 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedic...
TransMedics Group, Inc. (NASDAQ: TMDX) is the focus of IBN's latest stock spotlight. The company's shares have moved 0.38% on the day to $78.9. TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure p...
TransMedics Group, Inc. (NASDAQ: TMDX) has caught the attention of the investment community today with its bullish price action. The company's shares are currently up 13.76% on the day to $89.92. TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming or...
TransMedics to Report First Quarter 2023 Financial Results on May 1, 2023 PR Newswire ANDOVER, Mass. , April 17, 2023 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therap...
2023-03-10 07:31:28 ET The following slide deck was published by TransMedics Group, Inc. in conjunction with this event. For further details see: TransMedics Group (TMDX) Investor Presentation - Slideshow
Summary Triple-digit growth in top-line sales for the quarter and the year evidence the market's approval for TransMedics Group, Inc.'s offerings. TransMedics Group is addressing operational efficiencies in its transportation network. I am now looking for another 40% upside potentia...
News, Short Squeeze, Breakout and More Instantly...
TransMedics Group Inc. Company Name:
TMDX Stock Symbol:
NYSE Market:
TransMedics Group Inc. Website:
TransMedics to Report Second Quarter 2024 Financial Results on July 31, 2024 PR Newswire ANDOVER, Mass. , July 17, 2024 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant...
2024-07-04 23:50:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Shares of TransMedics Group, Inc. (NASDAQ: TMDX) traded at a new 52-week high today and are currently trading at $139.5. So far today, approximately 249.23k shares have been exchanged, as compared to an average 30-day volume of 655.52k shares. TransMedics Group, Inc., a commercial-stage medic...